Protea Biosciences Group, Inc.
company.status.inactiveCIK 1335103fmd_1SMCF4ZSTEBRH6CB5VNR4SB2P5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2001 to Jun 30, 2017, 38 periods
| Line item | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Cost of revenue | – | – | – | – | – | – | 1 | 1 | 1 | 2 |
| Gross profit | – | – | – | – | – | – | 0 | 1 | 1 | 1 |
| Research and development | – | – | – | 5 | 6 | 3 | 3 | 3 | 1 | 1 |
| Selling, general and administrative | – | – | – | 5 | 5 | 7 | 8 | 9 | 7 | 6 |
| Operating income | – | – | – | (9) | (11) | (9) | (10) | (11) | (7) | (5) |
| Interest expense | – | – | – | 0 | 1 | 1 | 1 | 1 | 2 | 2 |
| Other non-operating income (expense) | – | – | – | (0) | (1) | (1) | (1) | (1) | (2) | (10) |
| Income before taxes | – | – | – | (10) | (11) | (10) | (11) | (11) | (10) | (16) |
| Income tax expense | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | – | – | (10) | (11) | (10) | (11) | (11) | (10) | (16) |
| Net income | (3) | (4) | (5) | (10) | (11) | (10) | (11) | (11) | (10) | (16) |